Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is currently trading at 8,577.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Apollo Hospitals Enterprise Limited operates an integrated healthcare ecosystem spanning hospitals, diagnostics, primary-care clinics, pharmacies, digital health, telehealth, and day-surgery facilities across India. Its latest presentation shows 65 hospitals, 9,605 operational census beds, 7,662 pharmacy stores, 2,922 diagnostics centers, and a digital platform with more than 51 million registered users. Consolidated Q2 FY27 revenue increased 23% year over year to ₹76,149 million, while EBITDA rose 29% to ₹11,910 million and reported PAT increased 32% to ₹6,301 million. Growth was broad-based, with hospitals, diagnostics, pharmacy distribution, and digital health all delivering double-digit revenue expansion. The most important profitability inflection is in Apollo HealthCo’s digital business. Apollo 24|7 and online pharmacy reduced cash losses sharply and became pre-ESOP EBITDA positive at ₹13 million in Q2, while HealthCo’s overall cash profit reached ₹2,070 million, supported by stronger order economics and lower customer-acquisition spending. Apollo Hospitals Enterprise Limited is pursuing a substantial capacity cycle, with approximately 4,198 census beds remaining to be activated from the current expansion pipeline. Total planned project cost is approximately ₹11,152 crore, and the post-expansion network could reach roughly 13,800 census beds, creating significant long-term growth potential but also execution and capital-allocation demands. The proposed HealthCo composite scheme could unlock a separately listed, scaled healthcare-commerce platform combining Apollo’s pharmacy and digital assets with Keimed. Management expects the resultant New Co to reach an annualized ₹250 billion revenue and ₹15 billion EBITDA run-rate by Q4 FY27, subject to shareholder, NCLT, and other regulatory approvals.

Over the past 52 weeks, Apollo Hospitals Enterprise Ltd has traded between a low of ₹6,680.00 and a high of ₹9,326.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Apollo Hospitals Enterprise Ltd has a market capitalization of approximately 1,21,411.76. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Apollo Hospitals Enterprise Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 55.90 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,21,411.76 Cr, Apollo Hospitals Enterprise Ltd is classified as a Large Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Apollo Hospitals Enterprise Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Apollo Hospitals Enterprise Ltd is 55.90. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Apollo Hospitals reported consolidated net profit of ₹630 crore for Q2 FY27. This was 32% higher than ₹477 crore reported in the corresponding quarter of FY26.

Apollo Hospitals reported Q1 FY27 consolidated revenue of ₹7,044 crore and consolidated net profit of ₹610 crore, versus ₹5,842 crore and ₹441 crore in Q1 FY26.

Market snapshots in the feed showed Apollo Hospitals around Rs 8,888.50 to Rs 8,892.30 on July 6, 2026, roughly 0.06% lower in some updates.

Apollo Hospitals Enterprise entered the Nifty 50, replacing Indian Oil Corporation (IOC), effective March 31, 2022 (close of March 30, 2022).